- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00465582
B14 Meningococcal Carriage in Seine-Maritime Population: Prevalence Study and Search of Risk Factors
March 26, 2012 updated by: University Hospital, Rouen
Our main objectives are to evaluate the importance of meningococcal carriage and to determine the predisposing factors
Study Overview
Status
Terminated
Conditions
Study Type
Observational
Enrollment (Actual)
3296
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Seine-Maritime
-
Rouen, Seine-Maritime, France, 76000
- François Caron
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Dieppe Population 0 to 25 yaers old.
Description
Inclusion Criteria:
- Living in the area of Dieppe
- Parental authority assent if necessary
Exclusion Criteria:
- Child under supervision
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Prospective
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Francois Caron, Professor, Service des Maladies Infectieuses
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Study Completion (Actual)
April 1, 2008
Study Registration Dates
First Submitted
April 24, 2007
First Submitted That Met QC Criteria
April 24, 2007
First Posted (Estimate)
April 25, 2007
Study Record Updates
Last Update Posted (Estimate)
March 27, 2012
Last Update Submitted That Met QC Criteria
March 26, 2012
Last Verified
March 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2006/099/HP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Meningococcal Infections
-
Prof. Elizabeth MillerNovartis VaccinesCompletedMeningococcal Meningitis, Serogroup A | Meningococcal Meningitis, Serogroup B | Meningococcal Meningitis, Serogroup C | Meningococcal Meningitis, Serogroup Y | Meningococcal Meningitis, Serogroup WUnited Kingdom
-
Chiron CorporationUnknownMeningococcal Disease; Meningococcal MeningitisUnited Kingdom
-
EuBiologics Co.,LtdCompletedInfection, MeningococcalKorea, Republic of
-
GlaxoSmithKlineCompletedInfections, Meningococcal | Meningococcal VaccinesIndia, Lebanon, Philippines, Saudi Arabia
-
GlaxoSmithKlineCompletedMeningococcal Disease | Infections, MeningococcalColombia, Panama, Chile
-
GlaxoSmithKlineCompletedMeningococcal Disease | Infections, MeningococcalUnited States
-
EuBiologics Co.,LtdCompletedInfection, MeningococcalKorea, Republic of
-
GlaxoSmithKlineCompletedInfections, Meningococcal | Meningococcal VaccinesEstonia, Germany, Spain
-
Sanofi Pasteur, a Sanofi CompanyCompletedMeningitis | Meningococcal Infections | Meningococcal Meningitis | Invasive Meningococcal DiseaseUnited States
-
GlaxoSmithKlineCompletedInfections, Meningococcal | Meningococcal VaccinesGermany, France